Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

154.35 -0.06 (-0.04%)
Official Closing Price Updated: 7:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
62 63 Next >
These 6 Stocks Are Relentless Dividend Growers
Today I tell you about 6 dividend growth stocks that just increased their dividends. Check out the video for full details. 
Via Talk Markets
Kenvue Has Gone Public: Should You Buy the Stock?
Its business could be resistant to the effects of inflation. 
Via The Motley Fool
Which Is the Better Forever Stock: Johnson & Johnson or UnitedHealth Group?
Both stocks have built-in economic diversity and are solid long-term investments. 
Via The Motley Fool
Elliot Wave Technical Analysis: S&P 500 - Sunday, May 14
Via Talk Markets
Investing for the Long-Term? Here are 7 Must-Have Dividend Stocks
Here are seven must-have dividend stocks for long-term investing that you can consider for your dividend stock portfolio. 
Via InvestorPlace
Johnson & Johnson Unusual Options Activity
 
Via Benzinga
3 Bargain Dividend Stocks to Boost Your Passive Income
Here are just a few of the top bargain dividend stocks to boost your passive income as we get deeper into 2023. 
Via InvestorPlace
2 No-Brainer Healthcare Stocks to Buy Right Now
Boring businesses can make for beautiful lifelong holdings -- these two stocks show us why. 
Via The Motley Fool
Where to Invest $10,000 in a Bear Market
Cautious and aggressive investors both might find opportunities in a bear market. 
Via The Motley Fool
Promising Phase 1 Results: Protagonist Therapeutics and Janssen Biotech Unlock New Potential in Colitis and Inflammation Treatment
Protagonist Therapeutics (NASDAQ: PTGX) reported data from its collaboration with Janssen Biotech Inc, a unit of Johnson & Johnson (NYSE: JNJ), on Phase 1 and preclinical studies of  
Via Benzinga
How Apple Pleased Investors
We've got a lot of ground to cover as company earnings reports continue to flood in. 
Via The Motley Fool
7 Overvalued Stocks to Sell for May 2023
It's easy to fall into the trap of getting overvalued stocks. What may have been a great buy a year ago could be overvalued today. 
Via InvestorPlace
Tesla, IONQ, Nano-X, Peloton, Hepion: Why These 5 Stocks Are Drawing Investors' Attention Today
 
Via Benzinga
The Surprising Reason Nanox Stock Jumped Again Today
This $400 billion dollar company just increased its investment in Nanox by 62%. 
Via The Motley Fool
3 Healthcare Stocks to Buy and Hold for the Next 10 Years
These stocks may help your portfolio thrive over time. 
Via The Motley Fool
2 Warren Buffett Stocks to Buy Hand Over Fist in May
These two Berkshire Hathaway holdings are solid picks in May. 
Via The Motley Fool
Is ChatGPT A Better Financial Advisor? We're Going To Find Out
 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
3 Dividend Stocks Set to Hike Payouts in 2023
Here are three dividend stocks with rising dividends in 2023. Each stock is also a good buy-and-hold candidate in a volatile market. 
Via InvestorPlace
Artificial Intelligence Engine Predicts PACW Stock to Gain 11% by June 7
Watch our new video to find out how you can get 3,000 more predictions just like this 
Via InvestorPlace
Pharma ETFs Gain Post Q1 Earnings
Pharma ETFs have been in the green over the past month. 
Via Talk Markets
3 Dividend Stocks to Buy as the Healthcare Sector Booms in 2023
These best healthcare dividend stocks offer tremendous upside and stability in the current volatile macro environment 
Via InvestorPlace
3 Obvious Truths About Growth Stocks That Investors Often Forget
It's easy to get caught up in hype and miss what actually makes stocks go up. 
Via The Motley Fool
The 7 Best Mutual Funds to Invest in for May 2023
With rising uncertainties in the economy and the capital markets, investors have an incentive to consider the best mutual funds. 
Via InvestorPlace
Does Johnson & Johnson's Kenvue Spinoff Make Sense?
We also look at Darden Restaurants' acquisition and Yum! Brands' quarter. 
Via The Motley Fool
WHO Ends Global Emergency Status for COVID-19 3 Years After Declaration, CDC Director Resigns
The World Health Organization ended the global emergency 
Via Benzinga
The 7 Best Long-Term Dividend Stocks to Buy in May
These leading dividend stocks offer a blend of stability and long-term value for investors with an elongated investing horizon. 
Via InvestorPlace
These 2 Top Stocks Just Declared Dividend Raises
These companies manage to keep growing and generating excess profits, which is admirable given their age and size. 
Via The Motley Fool
Nasdaq, NYSE Stock Trading - Elliott Wave Analysis
Via Talk Markets
J&J's Kenvue Jumps 20% In Market Debut
Shares of Johnson & Johnson's consumer-health spin-off Kenvue soared 20% in their market debut on Thursday, making it the biggest U.S. IPO in over a year. Under Kenvue's umbrella are widely-known... 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
62 63 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.